Home › Core › ISCC-IDs › 28CrFZPFFriqs

View ISCC-ID

Core Data

28CrFZPFFriqs
ISCC-ID - digital asset identifier
CCrT6WyMCT7CA-CThdbeW7CRfm5-CDNjsECzpAuBx-CRDK1AWiXin6w
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

blood pressure effects of sglt2 inhibitors make them an attractive option in diabetic patients with hypertension

Ledger Reference

coblo
Source Ledger/Blockchain
6167
N-th ISCC Decleration on source ledger
598bb3f6e1a372fba995e588f339bee0b80b5d17eeb8bcb928d66fbedf31e8cf
Hash of block that includes the ISCC-DECLARATION
44afe505df5fe6937023ee55929641826d664e3cc1318cdb8f36f1607d4aa475
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Blood pressure effects of SGLT2 inhibitors make them an attractive option in diabetic patients with hypertension", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Michael J. Bloch", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.ashjournal.com/article/S1933171116000024/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Elsevier BV", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1016/j.jash.2016.01.001", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCrT6WyMCT7CA-CThdbeW7CRfm5-CDNjsECzpAuBx-CRDK1AWiXin6w", "propertyID": "ISCC"}], "datePublished": "2016-03-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close